Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-06-20

Clinical Trial Update: Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old [Phase 4]

View source ↗

Summary

Phase 4 safety trial update for the Enterovirus 71 vaccine in children 6-35 months old; no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enterovirus 71 Vaccine (Enterovirus 71 vaccine)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: Enterovirus 71 Vaccine | Phase 4 | Status: UNKNOWN